Related Experiment Video
Updated: Jun 7, 2026

07:46
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 16, 2010
Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation
H O Steinberg1, M Tarshoby, R Monestel
1Department of Medicine, Indiana University Medical Center, Indianapolis, Indiana 46202, USA.
The Journal of Clinical Investigation
|September 1, 1997
Summary
Elevated free fatty acids (FFAs) impair endothelial function, a key mechanism in insulin resistance. This study demonstrates that high FFA levels directly cause endothelial dysfunction in healthy humans.
Area of Science:
- Cardiovascular Physiology
- Metabolic Syndrome Research
- Endothelial Function Studies
Background:
- Insulin resistance and obesity are linked to impaired endothelial function.
- The direct role of elevated free fatty acids (FFAs) in causing endothelial dysfunction remains to be fully elucidated.
Purpose of the Study:
- To test the hypothesis that elevated circulating FFAs, similar to levels seen in insulin-resistant individuals, can impair endothelial function.
- To investigate the mechanisms underlying endothelial dysfunction in insulin resistance.
Main Methods:
- Healthy lean humans underwent infusions of Intralipid plus heparin or somatostatin (SRIF) to manipulate circulating FFA levels.
- Leg blood flow responses to endothelium-dependent (methacholine chloride) and endothelium-independent (sodium nitroprusside) vasodilators were measured.
- FFA and insulin levels were monitored throughout the infusions.
Main Results:
- Exogenous (Intralipid) and endogenous (SRIF-induced insulinopenia) elevation of FFAs significantly reduced methacholine chloride-induced vasodilation by approximately 20%.
- No significant changes in sodium nitroprusside-induced vasodilation were observed, indicating preserved smooth muscle function.
- Restoring basal insulin levels during SRIF infusion normalized FFA levels and prevented endothelial dysfunction.
Conclusions:
- Elevated circulating FFAs directly cause endothelial dysfunction.
- Impaired endothelial function in insulin-resistant individuals may be a consequence of elevated FFA concentrations.
Related Concept Videos
Inflammation
Overview
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...

